Perimenopausal anxiety and depressive symptoms
Conditions
Interventions
Intervention Group:Intervention Group: Receives an 8-week online integrated Dynamic Mindfulness group intervention. This includes: 1) Group Sessions: 8 sessions total (one 3-hour introductory session,
2) Home Practice: 6 days per week, each session lasting 60 minutes and led synchronously online by the facilitator via a video conference platform.
Wait-list Control Group:Live as usual and receive the same intervention after the intervention group ends.
Sponsors
School of Psychology Northwest Normal University
Eligibility
Sex/Gender
All
Age
40 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Assigned female at birth, aged 40-60 years. 2. In the perimenopausal stage, defined as: having experienced a change in menstrual cycle length of >=7 days (including irregularity or amenorrhea) within the past 3 months, or having experienced natural menopause but for less than 1 year. 3. Experiencing emotional distress, defined as: having a Patient Health Questionnaire-9 (PHQ-9) total score >=5 and/or a Generalized Anxiety Disorder-7 (GAD-7) total score >=5. 4. Exhibiting a cognitive profile of low mindfulness and high rumination, defined as: having a Five Facet Mindfulness Questionnaire (FFMQ) total score =23. 5. Able to stably use internet-enabled devices (smartphone or computer) to participate in online video group sessions. 6. Willing to participate in the study, capable of understanding and providing written informed consent.
Exclusion criteria
Exclusion criteria: 1. Menopause induced by surgical procedures (e.g., bilateral oophorectomy). 2. Systematic hormone replacement therapy (HRT) within the last three months, or regular use of antidepressant or anti-anxiety medications (occasional use of sleep aids is excluded). 3. Systematic participation in other forms of psychotherapy or mindfulness training courses before the start of the study. 4. Suffering from severe physical illnesses (e.g., malignant tumors, serious cardiovascular or cerebrovascular diseases) or being diagnosed with major mental disorders (e.g., schizophrenia, bipolar disorder), where the condition may significantly affect the assessment. 5. Assessment indicating a major depressive episode or high suicide risk (PHQ-9 total score >= 20, or a score >= 2 on item 9 of the PHQ-9 [suicidal ideation]). Such individuals will be excluded and advised to seek professional medical assistance immediately. 6. Experiencing major negative life events within the last six months (e.g., death of a spouse, death of an immediate family member, divorce, diagnosis of a serious illness in oneself or one’s spouse).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recruitment Success Rate;Intervention Retention Rate;Average Attendance Rate of Group Sessions;Qualified Adherence Rate to Home Practice;Overall Burden of Menopausal Symptoms;Severity of Anxiety Symptoms;Severity of Depressive Symptoms; | — |
Secondary
| Measure | Time frame |
|---|---|
| Subjective Sleep Quality;Constipation Symptom; | — |
Countries
China
Contacts
Public ContactXiaobin Ding
School of Psychology Northwest Normal University
Outcome results
None listed